Track-HD Reports Baseline Findings
Submitted by Marsha Miller Ph.D. on Sun, 12/06/2009
Clear differences were found among the control group, premanifest gene carriers, and those in early stages.
Submitted by Marsha Miller Ph.D. on Sun, 12/06/2009
Clear differences were found among the control group, premanifest gene carriers, and those in early stages.
Submitted by Marsha Miller Ph.D. on Sun, 10/21/2007
Submitted by Marsha Miller Ph.D. on Sat, 11/25/2006
Submitted by Marsha Miller Ph.D. on Sat, 09/16/2006
It has been awhile since a review of CAG counts in Huntington's Disease was published, so the new article by Dr. Michael Hayden and colleagues is very helpful. The normal, intermediate, and reduced penetrance ranges have changed over time and there have also been errors in publications. The authors present the most current information in the table below.
Submitted by Marsha Miller Ph.D. on Wed, 03/22/2006